Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Apr;39(4):185-91.
doi: 10.1002/clc.22503. Epub 2016 Apr 5.

Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database

Affiliations
Comparative Study

Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database

Yashashwi Pokharel et al. Clin Cardiol. 2016 Apr.

Abstract

We sought to determine use of any and at least moderate-intensity statin therapy in a national sample of patients with diabetes mellitus (DM), with the hypothesis that nationwide frequency and facility-level variation in statin therapy are suboptimal. We sampled patients with DM age 40 to 75 years receiving primary care between October 1, 2012, and September 30, 2013, at 130 parent facilities and associated community-based outpatient clinics in the Veterans Affairs Health Care System. We examined frequency and facility-level variation in use of any or at least moderate-intensity statin therapy (mean daily dose associated with ≥30% low-density lipoprotein cholesterol lowering). In 911 444 patients with DM, 68.3% and 58.4% were receiving any and moderate- to high-intensity statin therapy, respectively. Patients receiving statin had higher burden of cardiovascular disease, were more likely to be on nonstatin lipid-lowering therapy and to receive care at a teaching facility, and had more frequent primary-care visits. Median facility-level uses of any and at least moderate-intensity statin therapy were 68.7% (interquartile range, 65.9%-70.8%) and 58.6% (interquartile range, 55.8%-61.4%), respectively. After adjusting for several patient-related and some facility-related characteristics, the median rate ratios for any and moderate- to high-intensity statin therapy were 1.20 (95% confidence interval: 1.18-1.22) and 1.29 (95% confidence interval: 1.24-1.33) respectively, indicating 20% to 29% variation in statin use between 2 identical patients receiving care at 2 random facilities. Statin use was suboptimal in a national sample of patients with DM with modest facility-level variation, likely indicating differences in statin-prescribing patterns.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percentage of patients age 40 to 75 years with DM receiving any statin therapy at each of the 130 VA facilities. Abbreviations: DM, diabetes mellitus; VA, Veterans Affairs Health Care System.
Figure 2
Figure 2
Percentage of patients age 40 to 75 years with DM receiving moderate‐ to high‐intensity statin therapy at each of the 130 VA facilities. Abbreviations: DM, diabetes mellitus; VA, Veterans Affairs Health Care System.

Similar articles

Cited by

References

    1. Kearney PM, Blackwell L, Collins R, et al; Cholesterol Treatment Trialists' Collaborators . Efficacy of cholesterol‐lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta‐analysis. Lancet. 2008;371:117–125. - PubMed
    1. American Diabetes Association . Cardiovascular disease and risk management. Diabetes Care. 2015;38(suppl 1):S49–S57. - PubMed
    1. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;129(25 suppl 2):S46–S48]. Circulation. 2014;129(25 suppl 2):S1–S45. - PubMed
    1. Woodard LD, Landrum CR, Urech TH, et al. Treating chronically ill people with diabetes mellitus with limited life expectancy: implications for performance measurement. J Am Geriatr Soc. 2012;60:193–201. - PMC - PubMed
    1. Woodard LD, Landrum CR, Urech TH, et al. Impact of clinical complexity on the quality of diabetes care. Am J Manag Care. 2012;18:508–514. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources